Larimar Therapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDLarimar Therapeutics, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is weak (RS Rating: 30), showing significant lag compared to the market leaders. Earnings contraction of 62% provides fundamental context to the price action. Investors should exercise caution due to high volatility (117% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.47 | -10.58% | BELOW |
| 50 SMA | $4.74 | -15.61% | BELOW |
| 100 SMA | $4.13 | -3.09% | BELOW |
| 150 SMA | $4.05 | -1.28% | BELOW |
| 200 SMA | $4.01 | -0.36% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LRMR in an uptrend right now?
LRMR has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is LRMR overbought or oversold?
LRMR's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is LRMR outperforming the market?
LRMR has a Relative Strength (RS) Rating of 30 out of 99. LRMR is currently lagging the broader market.
Where is LRMR in its 52-week range?
LRMR is trading at $4.00, which is 62% of its 52-week high ($6.42) and 48% above its 52-week low ($1.73).
How volatile is LRMR?
LRMR has a Beta of 2.17 and 52-week volatility of 117%. It's more volatile than the S&P 500 - expect bigger swings.